Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Working Capital Changes (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Other Working Capital Changes data on record, last reported at $62000.0 in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 94.5% year-over-year to $62000.0; the TTM value through Oct 2025 reached $419000.0, up 161.71%, while the annual FY2025 figure was -$144000.0, 186.23% down from the prior year.
  • Other Working Capital Changes reached $62000.0 in Q4 2025 per CSBR's latest filing, up from -$154000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.5 million in Q2 2023 and bottomed at -$1.8 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $119052.6, with a median of $62000.0 recorded in 2025.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 1784.62% in 2021, then plummeted 778.49% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $651000.0 in 2021, then plummeted by 53.92% to $300000.0 in 2022, then surged by 508.33% to $1.8 million in 2023, then plummeted by 38.25% to $1.1 million in 2024, then plummeted by 94.5% to $62000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $62000.0 in Q4 2025, -$154000.0 in Q3 2025, and $638000.0 in Q2 2025.